Details of the Drug

General Information of Drug (ID: DMBN3YQ)

Drug Name

PNT-2002

Indication

Disease Entry	ICD 11	Status	REF
Prostate cancer	2C82.0	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Radiopharmaceutical

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04647526) A Phase 3, Open-Label, Randomized Study Evaluating Metastatic Castrate Resistant Prostate Cancer Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment (SPLASH). U.S.National Institutes of Health.